Close Menu

Everyone rants about peer review, but what isn't very well known is that the process serves two purposes, says Chris Lee at Ars Technica. It both decides the value of research — something Lee says it does very well — and serves as "a gatekeeper for scientific funding" — which, Lee says, it doesn't do as well. In the first case, the great benefit to peer review is that it examines a researcher's methods well, Lee says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.